« Previous
Next »
Titles
- FDA drug approval: application review times largely reflect FDA goals : report to Congressional requesters1
- FDA drug approval: application review times largely reflect agency goals : report to Congressional requesters1
- FDA oversight2
- FDA’s risk evaluation and mitigation strategies: uncertain effectiveness in addressing the opioid crisis1
- FH Healthcare Indicators and FH Medical Price Index 2021: an annual view of place of service trends and medical pricing1
- FH Healthcare Indicators and FH Medical Price Index: 2020 : an annual view of place of service trends and medical pricing1
- Facilitating consumer choice: standardized plans in health insurance marketplaces1
- Facility quality and safety2
- Facility-initiated discharges in nursing homes require further attention1
- Family engagement and California’s Whole Child Model: lessons learned from the implementation of family advisory committees1
- Family presence during a pandemic: guidance for decision-making family presence during a pandemic: guidance for decision-making1
- Family spillover effects of marginal diagnosis: the case of ADHD1
- Family structures and support strategies in the older population: implications for baby boomers1
- Fathers advancing community together: findings from a participant survey1
- Federal Medicaid policy2
- Federal public policy and legislative solutions for improving maternal health1
- Federal research: NIH should take further action to address foreign influence : testimony before the Committee on Health, Education, Labor and Pensions, U.S Senate1
- Fertility Knowledge Survey, 2020: findings report1
- Few patients received high amounts of opioids from IHS-run pharmacies1
- Few unvaccinated adults have talked to their doctors about the COVID-19 vaccines: findings from the April 2021 Health Reform Monitoring Survey1